The circulation of health data will be facilitated under certain conditions within the EU. Photo: Shutterstock

The circulation of health data will be facilitated under certain conditions within the EU. Photo: Shutterstock

The regulation on the European Health Data Area comes into force. The aim is to promote secure access to health data throughout the European Union for patients and researchers. Its impact will not be felt until 2029, the time needed to adapt the technical and legal infrastructures.

The European Health Data Space (EEDS) is the first sector-specific version of the Digital Governance Act (DGA) rules designed to guarantee the security and free movement of data in the EU. These regulations are based on two pillars: improving individuals' access to and control over their health data, both at national and European level--known as "primary use”--and, secondly, re-using data for research, innovation, regulatory and public policy purposes. This is known as "secondary use".

The first part concerns patients and sets out the conditions under which their electronic health data can be shared. More broadly, the EEDS will ensure that all the electronic records that exist in the Member States can communicate with each other. The benefits are obvious. Just think of a tourist who has an accident abroad. His treatment will be facilitated if local medical teams can quickly access his medical file without delay and thus find out his history and any allergies to medication.

The limits of consent in a life-threatening emergency

With EEDS, patients have total control over their data. They can modify it at any time, restrict access to it and see who has used it. And the organisations that manage this data are bound by medical confidentiality. Just as they are required to maintain confidentiality and security.

Access to data, once authorised, is subject to strict controls. For the purposes of the regulation, the following are considered to be shareable data: a summary of the patient's medical record, prescriptions, dispensations--including medicines dispensed via a current electronic prescription--test results and discharge letters.

However, the issue of breaking the glass--access to data in the event of a life-threatening emergency even if the individual refuses to share--gave rise to enough controversy during the negotiation of the text for the subject to be referred back to national legislation. It will therefore be up to the Luxembourg government to decide on this point. But the bottom line is that all health data will have to be recorded. Recording data and sharing it are two different things. We must never forget this.

The regulation also states that all health records will have to be adapted. The member states have four years in which to share patient medical summaries, prescriptions and dispensations. And a further two years for sharing imaging, laboratory results and hospital discharge letters.

Multiple records possible for cross-border commuters

As health remains a matter for the member states, the regulation does not create a European health file. The reference file will be the affiliation file. To take account of the free movement of individuals, the system allows a patient to have several files. This is essential for cross-border commuters. In the event of treatment abroad, a file will be created and the data will be pushed to the reference file, the affiliation file. And in all cases, patients can push their data from one file to another if they wish.

The second part of the regulation concerns secondary use, i.e. the re-use of data for research, innovation and public policy purposes. The data will be structured in specific common formats and will be anonymised or pseudonomised if anonymisation is not possible. This sharing will help to optimise public health policies and encourage research activities, and hence innovation.

This type of use of health data is already made possible by the General Data Protection Regulation (GDPR). The big difference is that while the GDPR proceeded on an ad hoc, request-by-request basis, the EEDS Regulation adopts a global approach. Member countries are now required to list all the health data they hold--patient data and clinical studies in particular--in a catalogue. The body in charge of managing this data--Luxembourg has not yet determined what this body will be--will have to publish this catalogue. Interested researchers will have to say which data they want to use and why. The data will under no circumstances be transmitted, but will be available for consultation in secure environments.

Regulatory work for the government

The EEDS regulation will be implemented in stages. Firstly, Member States will have to adapt their national electronic medical record systems. In Luxembourg, the e-Santé agency will be responsible for adapting the shared health record (DSP). The government will also have to decide which bodies will be responsible for data exchange. In terms of secondary use, the regulation establishes "health data access bodies". Each Member State must have one. It is understood that there may be one body or several bodies responsible for certain parts of the entire process, according to the regulation. In the latter case, a coordinator will have to be appointed. The question of governance for everything to do with primary use will be addressed during the development of the health digitalisation programme launched by the Ministry. The question of the role of the National Commission for Data Protection (CNPD) in this scheme has not yet been decided.

This article was originally published in French.